Except for Apigenin, HMF and Luteolin, the target genes (exclusion of DPP4) of the remaining nine compounds were significantly enriched in DKD-related signalling pathways (Figure 3B; Table 1). This evidence concerns the gene DPP4 and diabetic kidney disease.